Pharming Group NV
NASDAQ:PHAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharming Group NV
NASDAQ:PHAR
|
NL |
|
P
|
Pecoy Copper Corp
OTC:PCUUF
|
CA |
|
Perenti Global Ltd
ASX:PRN
|
AU |
|
Bank Rakyat Indonesia (Persero) Tbk PT
IDX:BBRI
|
ID |
|
Fujifilm Holdings Corp
TSE:4901
|
JP |
|
Companhia de Saneamento Basico do Estado de Sao Paulo SABESP
NYSE:SBS
|
BR |
|
Laboratorio Reig Jofre SA
MAD:RJF
|
ES |
Wall St Price Targets
PHAR Price Targets Summary
Pharming Group NV
According to Wall Street analysts, the average 1-year price target for PHAR is 26.61 USD with a low forecast of 21.44 USD and a high forecast of 32.19 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHAR's stock price target?
Price Target
26.61
USD
According to Wall Street analysts, the average 1-year price target for PHAR is 26.61 USD with a low forecast of 21.44 USD and a high forecast of 32.19 USD.
What is the Revenue forecast for Pharming Group NV?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.
What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
36%
The compound annual growth rate for Operating Income over the next 5 years is 36%.
What is the Net Income forecast for Pharming Group NV?
Projected CAGR
130%
The compound annual growth rate for Net Income over the next 4 years is 130%.
